Andarix Pharmaceuticals Andarix Pharmaceuticals is a company developing and commercializing novel cancer therapies that are targeted to the patients most likely to respond. | OncoHost OncoHost is a clinical-stage precision oncology company that develops a host response profiling platform (PROphetTM) for cancer therapies. | |||
Founding Date | Founding Date 2018 | Founding Date N/A | Founding Date 2017 | Founding Date 2017 |
Type | Type Private | Type Private | Type Private | Type Subsidiary |
Tags | ||||
Locations | Locations Geneva, CH HQ | Locations HQ | Locations Binyamina-Giv'at Ada, IL HQ | Locations Rahway, US HQ |
Employees | Employees 7 | Employees N/A | Employees 562% decrease | Employees 6 |
Funding | ||||
Latest funding round | Latest funding round $ 1.6m (over 3 years ago) | Latest funding round N/A | Latest funding round $ 35m (about 4 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 1.6m | Total funding raised N/A | Total funding raised $ 43m | Total funding raised $ 202.7m |
Andarix Pharmaceuticals is a company developing and commercializing novel cancer therapies that are targeted to the patients most likely to respond.
View companyOncoHost is a clinical-stage precision oncology company that develops a host response profiling platform (PROphetTM) for cancer therapies.
View company
VelosBio is a clinical-stage biopharmaceutical company engaged in oncology research.
View company